An investigation into the prevalence of anemia in patients diagnosed with type 2 diabetes mellitus who were treated at a tertiary care hospital

Abstract

To provide some context, diabetes mellitus refers to a collection of metabolic illnesses that affect the metabolism of carbohydrates. Studies have shown that diabetics have a twofold higher incidence of anemia compared to people who do not have diabetes. The development of anemia is an extra burden that is added to the microvascular issues that are associated with diabetes. In spite of these facts, twenty-five percent of diabetic patients do not seek medical attention for anemia. The goals are: 1. To conduct research on the degree to which patients with type 2 diabetes mellitus experience acute anemia 2. To investigate the significance of anemia as a clinical indication of prognosis in patients diagnosed with type 2 diabetes mellitus as a method: A prospective clinical study was carried out at selected tertiary hospital during the months of August 2022 and January 2024. The study involved 125 patients who were evaluated for type 2 diabetes mellitus and were admitted to the inpatient department of general medicine. The relevant inferential statistics were utilized in order to analyze the data. Based on the findings of the study, it was found that out of a total of 125 patients, 78 (36.5%) were females, while 47 (37.5%) were males. Among the observations that fall into the HbA1c >10 group, the majority of them (86.7% of them) have a Severe Hb. Significantly more than sixty-three percent of people who have had diabetes for more than ten years have significant Hb severity. The findings of this study indicate that there is a requirement for periodic hematological screening in all diabetic patients who present themselves to the hospital, as well as treatment of anemia, in order to achieve a more favorable outcome and reduce the risk of complications.